查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球血管造影导管市场 - 2023-2030年
市场调查报告书
商品编码
1290362

全球血管造影导管市场 - 2023-2030年

Global Angiographic Catheters Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球血管造影导管市场在2022年达到12.573亿美元，预计到2030年将见证有利可图的增长，达到22.298亿美元。在预测期内（2023-2030年），全球血管造影导管市场预计将呈现7.6%的复合增长率。医疗设备的快速技术进步，以及政府对医疗基础设施建设的支出增加，是推动全球血管造影导管市场的重要因素。

血管造影导管在介入心脏病学和放射学领域极为重要。这些导管是专门的医疗设备，用于观察血管并进行诊断和治疗。

市场动态

心血管疾病的发病率不断增加

心血管疾病的发病率不断上升，如冠状动脉疾病、周围动脉疾病和心脏病发作，导致对诊断和介入程序的需求不断增加。血管造影导管是进行血管造影的重要工具，可以观察和评估血管，有助于这些疾病的诊断和治疗。

同时，技术的进步也推动了血管造影市场的发展，使其性能和安全性得到提高。诸如改进的成像能力、更好的导管材料和增强的可操作性等创新，使手术更加精确和微创，导致这些导管的采用和需求增加。

严格的监管要求

血管造影导管市场需要接受严格的监管，并符合各种医疗设备的规定。满足这些要求会增加与产品开发和批准相关的时间和成本。

保险公司的报销政策和覆盖范围会影响血管造影导管的采用。如果报销率低，或者某些涉及血管造影导管的手术不在保险范围内，医疗机构和供应商可能不愿意投资于这些设备或进行这些手术。

COVID-19影响分析

血管造影导管市场通过各种因素受到COVID-19的巨大影响，如手术量减少。在大流行期间，许多医院和医疗机构经历了选择性手术的大幅减少，包括非紧急的血管造影手术。这种手术量的下降直接影响了对血管造影导管的需求。

由于医疗系统的压力和优先考虑资源的需要，出现了一个转变，即主要为紧急或紧急病例进行血管造影手术。这一转变降低了血管造影导管的总体利用率。

大流行病造成的全球供应链中断导致了包括血管造影导管在内的医疗设备的生产、分销和供应方面的挑战。生产设施面临临时关闭、运输限制和原材料短缺，导致延误和供应链中断。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按产品类型分類的摘要
  • 按应用分类的摘要
  • 按终端用户分类

第四章：动态变化

  • 影响因素
    • 驱动因素
      • 心血管疾病的发病率不断上升
    • 限制因素
      • 严格的监管要求
    • 机会
      • 研究与开发活动的增长
    • 影响分析

第五章：行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第七章：按产品类型

  • 缩管球囊导管
  • 常规导管
  • 切割球囊导管
  • 药物洗脱型球囊导管

第八章：按应用分类

  • 血管内
  • 冠状动脉
  • 神经科
  • 肿瘤学
  • 其他

第九章：按终端用户分类

  • 医院
  • 专业诊所
  • 非住院手术中心
  • 其他

第十章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第11章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併和收购分析

第十二章 ：公司简介

  • Medtronic
      • 公司概述
      • 产品组合和描述
      • 财务概况
      • 主要发展情况
  • 波士顿科学公司
  • 泰尔茂医疗公司
  • 卡迪纳尔健康公司
  • Merit Medical Systems, Inc.
  • 阿博特
  • 亚琛共振公司（Aachen Resonance Entwicklungsgesellschaft Mbh
  • ZOLL医疗公司
  • Contego Medical, Inc
  • Asahi Intecc Co.Ltd.）。

第十三章 ：附录

简介目录
Product Code: MD1318

Market Overview

The Global Angiographic Catheters Market reached US$ 1,257.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,229.8 million by 2030. The global angiographic catheters market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030). Rapid technical advancements in medical equipment, as well as rising government expenditures for the construction of healthcare infrastructure, are important factors driving the global angiographic catheters market.

Angiographic catheters are extremely important in the fields of interventional cardiology and radiology. These catheters are specialized medical devices that are used to see blood vessels and perform diagnostic and therapeutic treatments.

Market Dynamics

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular conditions such as coronary artery disease, peripheral artery disease, and heart attacks has led to a growing need for diagnostic and interventional procedures. Angiographic catheters are essential tools in performing angiography to visualize and assess blood vessels, aiding in the diagnosis and treatment of these diseases.

Also, technological advancements drive the angiographic market in such a way that it has improved their performance and safety. Innovations such as improved imaging capabilities, better catheter materials, and enhanced maneuverability have made procedures more accurate and minimally invasive, leading to increased adoption and demand for these catheters.

Stringent Regulatory Requirements

The angiographic catheter market is subject to strict regulatory oversight and compliance with various medical device regulations. Meeting these requirements can increase the time and cost associated with product development and approval.

Reimbursement policies and coverage by insurance providers can impact the adoption of angiographic catheters. If reimbursement rates are low or if certain procedures involving angiographic catheters are not covered, healthcare facilities and providers may be reluctant to invest in these devices or perform the procedures.

COVID-19 Impact Analysis

The angiographic catheters market was hugely affected by COVID-19 through various factors like decreased procedure volumes. During the pandemic, many hospitals and healthcare facilities experienced a significant reduction in elective procedures, including non-emergency angiographic procedures. This decline in procedure volumes directly affected the demand for angiographic catheters.

Due to the strain on healthcare systems and the need to prioritize resources, there was a shift towards performing angiographic procedures primarily for urgent or emergency cases. This shift reduced the overall utilization of angiographic catheters.

The global supply chain disruptions caused by the pandemic resulted in challenges in the production, distribution, and availability of medical devices, including angiographic catheters. Manufacturing facilities faced temporary closures, transportation restrictions, and shortages of raw materials, leading to delays and supply chain interruptions.

Segment Analysis

The global angiographic catheters market is segmented based on product type, application and end user.

The Scoring Balloon Catheters in Product Segment will be Dominated by Market Players During the Forecast Period

The scoring balloon catheters segment is expected to hold a substantial share of around 37.2% in the angiography catheter market. Where scoring balloon catheters are used during certain interventional procedures, both scoring balloon catheters and angiography catheters may be used in sequence. For example, during an angioplasty procedure, an angiography catheter is first used to obtain diagnostic images of the affected blood vessels. Once the lesion has been identified, a scoring balloon catheter may be introduced to facilitate lesion modification and optimize vessel dilation.

Geographical Analysis

North America is the Dominating Region Accounting for 41.7% During the Forecast Period

North America is the dominating region for the angiographic catheters market due to well-developed healthcare infrastructure and a high level of healthcare spending, which further supports the market growth. Technological advancements in angiographic catheters, such as the development of new materials, improved designs, and enhanced imaging capabilities, also contribute to market expansion.

Factors that influence the market for angiographic catheters include the prevalence of cardiovascular diseases, advancements in technology, healthcare infrastructure, and reimbursement policies. North America, particularly the United States, has a significant burden of cardiovascular diseases, which drives the demand for angiographic catheters.

Competitive Landscape

The major global players include: Medtronic, Boston Scientific Corporation, Terumo Medical Corporation, Cardinal Health, Merit Medical Systems, Inc, Abbott, Aachen Resonance Entwicklungsgesellschaft Mbh, Zoll Medical Corporation, Contego Medical, Inc, and Asahi Intecc Co. LTD.

Why Purchase the Report?

  • To visualize the global angiographic catheters market segmentation based on the treatment, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global angiographic catheters market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global angiographic catheters market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of cardiovascular diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Requirements
    • 4.1.3. Opportunity
      • 4.1.3.1. Growth in R & D activities
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1 Scoring Balloon Catheters
  • 7.2 Conventional Catheters
  • 7.3 Cutting Balloon Catheters
  • 7.4 Drug-Eluting Balloon Catheters

8. By Application

  • 8.1. Endovascular
  • 8.2. Coronary
  • 8.3. Neurology
  • 8.4. Oncology
  • 8.5. Others

9. By End User

  • 9.1. Hospitals
  • 9.2. Specialty Clinics
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic
      • 12.1.1.1. Company Overview
      • 12.1.1.2. Product Portfolio and Description
      • 12.1.1.3. Financial Overview
      • 12.1.1.4. Key Developments
  • 12.2. Boston Scientific Corporation
  • 12.3. Terumo Medical Corporation
  • 12.4. Cardinal Health
  • 12.5. Merit Medical Systems, Inc.
  • 12.6. Abbott
  • 12.7. Aachen Resonance Entwicklungsgesellschaft Mbh
  • 12.8. ZOLL Medical Corporation
  • 12.9. Contego Medical, Inc
  • 12.10. Asahi Intecc Co. Ltd.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us